patterns of progression on crizotinib for alk nsclc
Published 7 years ago • 325 plays • Length 4:38Download video MP4
Download video MP3
Similar videos
-
6:51
progression in alk nsclc after frontline therapy
-
7:02
crizotinib for alk-rearranged nsclc
-
6:04
case study: progression on alk inhibitors in nsclc
-
1:22
dr. crinò on crizotinib in alk nsclc
-
4:10
crizotinib resistance in alk nsclc
-
5:14
progression of alk nsclc
-
3:21
phase 1 study of crizotinib in patients with alk-positive non-small cell lung cancer
-
0:39
continuation of ceritinib beyond disease progression in alk-positive nsclc
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
8:11
treating alk-mutated nsclc with disease progression
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
0:44
dr. mark kris discusses crizotinib for patients with alk-positive lung cancer
-
4:37
development of alk inhibitors in advanced non-small cell lung cancer
-
1:18
real-world treatment patterns of alectinib in unselected spanish alk nsclc patients | oncotarget
-
4:00
alectinib eclipses crizotnib for alk positive lung cancer
-
13:28
debate: alk positive nsclc - front line therapy - crizotinib
-
1:27
dr. ou on the use of crizotinib in patients with ros1-rearranged nsclc
-
5:19
ascend-5: ceritinib for alk positive nsclc previously treated with crizotinib